Ceramide, a mediator of interleukin 1, tumour necrosis factor α, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells

Annals of the Rheumatic Diseases

Volumn 57, Issue 8, 1998, Pages 495-499

  Mizushima, Noboru ^a   Kohsaka, Hitoshi ^a   Miyasaka, Nobuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CERAMIDE; DNA; FAS LIGAND; INTERLEUKIN 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SECOND MESSENGER; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SYNOVIOCYTE;

EID: 0031752469     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.8.495     Document Type: Article

References (45)

1. Butler DM, Piccoli DS, Hart PH, Hamilton JA. Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines. J Rheumatol 1988;15:1463-70.
2. Butler DM, Leizer T, Hamilton JA. Stimulation of human synovial fibroblast DNA synthesis by platelet-derived growth factor and fibroblast growth factor. Differences to the activation by IL-1. J Immunol 1989;142:3098-103.
3. Hamilton JA, Butler DM, Stanton H. Cytokine interaction promoting DNA synthesis in human synovial fibroblasts. J Rheumatol 1994;21:797-803.
4. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum 1996;39:197-203.
5. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
6. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995; 38:485-91.
7. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
8. Hasunuma T, Hoa TT, Aono H, Asahara H, Yonehara S, Yamamoto K, et al. Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis. Int Immunol 1996;8:1595-602.
9. Kim M-Y, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon. J Biol Chem 1991;266:484-9.
10. Yanaga F, Watson SP. Ceramide does not mediate the effect of tumour necrosis factor α on superoxide generation in human neutrophils. Biochem J 1994;3:733-8.
11. Wiegmann K, Schutze S, Kampen E, Himmler A, Machleidt T, Kronke M. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem 1992;267:17997-8001.
12. Dbaibo GS, Obeid LM, Hannun YA. Tumor necrosis factor-α (TNFα) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNFα from activation of nuclear factor-κB. J Biol Chem 1993;268: 17762-6.
13. Ballou LR, Chao CP, Holness MA, Barker SC, Raghow R. Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 1992;267:20044-50.
14. Mathias S, Younes A, Kan CC, Orlow I, Joseph C, Kolesnick RN. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 1993;259:519-22.
15. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 1995;20:73-7.
16. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994;77:325-8.
17. Olivera A, Buckley NE, Spiegel S. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J Biol Chem 1992;267:26121-7.
18. Hauser JML, Buehrer BM, Bell RM. Role of ceramide in mitogenesis induced by exogenous sphingoid bases. J Biol Chem 1994;269:6803-9.
19. Laulederkind SJF, Bielawska A, Raghow R, Hannun YA, Ballou LR. Ceramide induces interleukin 6 gene expression in human fibroblasts. J Exp Med 1995;182:599-604.
20. Santana P, Peña LA, Haimovitz-Friedman A, Martin S, Green D, McLoughin M, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996;86:189-99.
21. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1993;177:1547-52.
22. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 1995;2:341-51.
23. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, et al. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 1995;92:8443-7.
24. Cifone MG, Roncaioli P, De MR, Camarda G, Santoni A, Ruberti G, Testi R. Multiple pathways originate at the Fas/Apo-1 (CD95) receptor: sequential involvment of phosphatidylchotine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 1995;14:5859-68.
25. Kumkumian GK, Lafyatis R, Remmers EF, Case JP, Kim S-J, Wilder RL. Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription. J Immunol 1989;143:833-7.
26. Arnen FC, Edworthy SM, Bloch DJ, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Okazaki T, Bell RM, Hannun YA. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. J Biol Chem 1989; 264:19076-80.
28. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994;265: 1596-9.
29. Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Pushkareva M, et al. Role for ceramide in cell cycle arrest. J Biol Chem 1995;270:2047-52.
30. Boucher LM, Wiegmann K, Futterer A, Pfeffer K, Machleidt T, Schutze S, et al. CD28 signals through acidic sphingomyelinase. J Exp Med 1995;181:2059-68.
31. Chan G, Ochi A. Sphingomyelin-ceramide turnover in CD28 costimulatory signaling. Eur J Immunol 1995;25: 1999-2004.
32. Bielawska A, Crane HM, Liotta D, Obeid LM, Hannun YA. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J Biol Chem 1993;268: 26226-32.
33. Kolesnick R, Fuks Z. Ceramide: a signal for apoptosis or mitogenesis? J Exp Med 1995;181:1949-52.
34. Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin-1 a potential regulator of fibroblast proliferation. J Immunol 1982;128:2177-82.
35. Sugarman BJ, Aggarwal BB, Hass PE. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 1985;230:943-5.
36. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994;78:680-92.
37. Rothe M, Sarma V, Dixit VM, Goeddel DV. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 1995;269:1424-7.
38. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature 1996;383:443-6.
39. Mizushima N, Koike R, Kohsaka H, Kushi Y, Handa S, Yagita H, et al. Ceramide induced apoptosis via CPP32 activation. FEBS Lett 1996;395:267-71.
40. Mashima T, Naito M, Fujita N, Noguchi K, Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement os an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun 1995;217:1185-92.
41. Kayalar C, Örd T, Testa P, Zhong L-T, Bredesen DE. Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 1996; 93:2234-8.
42. Brancolini C, Benedetti M, Schneider C. Microfilament reorganization during apoptosis: the role of Gas2, a possible substrate for ICE-like proteases. EMBO J 1995;14:5179-90.
43. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997;276:1571-4.
44. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, et al. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 1997;278: 294-8.
45. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994;37: 1415-20.